These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 15627885)

  • 41. A systematic review and meta-analysis of diagnostic and prognostic serum biomarkers of colorectal cancer.
    Liu Z; Zhang Y; Niu Y; Li K; Liu X; Chen H; Gao C
    PLoS One; 2014; 9(8):e103910. PubMed ID: 25105762
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Colon cancer-specific antigen-2 may be used as a detecting and prognostic marker in colorectal cancer: a preliminary observation.
    Xue G; Wang X; Yang Y; Liu D; Cheng Y; Zhou J; Cao Y
    PLoS One; 2014; 9(4):e94252. PubMed ID: 24710115
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Circulating and stool nucleic acid analysis for colorectal cancer diagnosis.
    De Maio G; Rengucci C; Zoli W; Calistri D
    World J Gastroenterol; 2014 Jan; 20(4):957-67. PubMed ID: 24574768
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative study of CEA and CA19-9 in esophageal, gastric and colon cancers individually and in combination (ROC curve analysis).
    Bagaria B; Sood S; Sharma R; Lalwani S
    Cancer Biol Med; 2013 Sep; 10(3):148-57. PubMed ID: 24379990
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Negative prognostic factors in colorectal carcinoma: An analysis of 448 patients.
    Caliskan C; Guler N; Karaca C; Makay O; Firat O; Korkut MA
    Indian J Surg; 2010 Jun; 72(3):243-8. PubMed ID: 23133256
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Total mesorectal excision for rectal cancer in an unselected population: quality assessment in a low volume center.
    Ferenschild FT; Dawson I; de Wilt JH; de Graaf EJ; Groenendijk RP; Tetteroo GW
    Int J Colorectal Dis; 2009 Aug; 24(8):923-9. PubMed ID: 19488771
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A simple and reproducible scoring system for EGFR in colorectal cancer: application to prognosis and prediction of response to preoperative brachytherapy.
    Zlobec I; Vuong T; Hayashi S; Haegert D; Tornillo L; Terracciano L; Lugli A; Jass J
    Br J Cancer; 2007 Mar; 96(5):793-800. PubMed ID: 17311026
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancer.
    Zlobec I; Steele R; Terracciano L; Jass JR; Lugli A
    J Clin Pathol; 2007 Oct; 60(10):1112-6. PubMed ID: 17182662
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [CEA, CA 19.9 and CA 195 in patients with colorectal carcinoma. ROC analysis].
    Vallejo J; Torres-Avisbal M; Contreras P; Rodríguez-Liñán M; Rebollo A; González F; Benítez A; Infante J; Mateo A
    Rev Esp Med Nucl; 1999 Aug; 18(4):281-6. PubMed ID: 10481111
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Antigens (CEA and CA 19-9) in diagnosis and prognosis colorectal cancer].
    Grotowski M
    Pol Merkur Lekarski; 2002 Jan; 12(67):77-80. PubMed ID: 11957811
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CEA, CA 242, CA 19-9, CA 72-4 and hCGbeta in the diagnosis of recurrent colorectal cancer.
    Carpelan-Holmström M; Louhimo J; Stenman UH; Alfthan H; Järvinen H; Haglund C
    Tumour Biol; 2004; 25(5-6):228-34. PubMed ID: 15627885
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Estimating the probability of cancer with several tumor markers in patients with colorectal disease.
    Carpelan-Holmström M; Louhimo J; Stenman UH; Alfthan H; Järvinen H; Haglund C
    Oncology; 2004; 66(4):296-302. PubMed ID: 15218297
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum HCG beta, CA 72-4 and CEA are independent prognostic factors in colorectal cancer.
    Louhimo J; Carpelan-Holmström M; Alfthan H; Stenman UH; Järvinen HJ; Haglund C
    Int J Cancer; 2002 Oct; 101(6):545-8. PubMed ID: 12237895
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combination of HCGbeta, CA 19-9 and CEA with logistic regression improves accuracy in gastrointestinal malignancies.
    Louhimo J; Finne P; Alfthan H; Stenman UH; Haglund C
    Anticancer Res; 2002; 22(3):1759-64. PubMed ID: 12168865
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma.
    Zhang SY; Lin M; Zhang HB
    Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Postoperative CEA is a better prognostic marker than CA19-9, hCGβ or TATI after resection of colorectal liver metastases.
    Peltonen R; Österlund P; Lempinen M; Nordin A; Stenman UH; Isoniemi H
    Tumour Biol; 2018 Jan; 40(1):1010428317752944. PubMed ID: 29378497
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.